Kiran Relekar is an expert in the field of Internal Medicine. He went to New York Medical College. Doctor Kiran V. Relekar, MD is also a published doctor. He has 2 paper published. The most recent paper is: A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma. He accepts all Medicare patients.
NPI NUMBER | 1245533231 | |
NPPES Provider LastName | RELEKAR | |
NPPES Provider FirstName | KIRAN | |
NPPES Provider ZIPCode | 432143912 | |
NPPES Provider State | OH | |
Specialty Description | Internal Medicine | |
Total Claim Count | 212.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1245533231 |
Last Name Of The Provider | RELEKAR |
First Name Of The Provider | KIRAN |
View All |
Dr. Jennifer R. White, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Scott A. Holliday, MD | |
Dr. Lisa Z. Mewhort, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Sanath K. Allampati, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Jennifer E. Thomas, DO
This Doctor is OpenDoctor Recommended. |
|
Dr. Lyle T. Olson, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Sarah L. Lim, DO | |
Dr. Rustum A. Shahzad, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Jessica L. Barrett, DO | |
Dr. Christopher L. Schumann, MD | |
Dr. Chirag R. Patel, DO
This Doctor is OpenDoctor Recommended. |
|
Dr. Adam G. Manko, MD
This Doctor is OpenDoctor Recommended. |